Update on the NIH Chelation Trial

The federal Trial to Assess Chelation (TACT) study is once again enrolling heart attack survivors. The study’s leader, Dr. Gervasio Lamas of the Mt. Sinai Medical Center in Miami, voluntarily suspended enrollment last fall after allegations were published in Medscape critical of the consent form given to patients and of the safety of the trial.The […]

Read More

Big Pharma and the FDA: Suppress the Science, Ban the Natural Substances, Sell the Drugs!

In 2005, an up-and-coming pharmaceutical company made a big mistake: they invested millions of dollars into developing a drug only to discover that the only active ingredient of the drug, pyridoxamine, was really a common, naturally occurring substance that has been sold for decades at low cost to consumers in the form of a dietary […]

Read More

FDA to Receive More Money from Drug Manufacturers, But Denies “Undue Influence”

The proposed budget of the US Food and Drug Administration (FDA) is worrying the Democrats. They are concerned that FDA’s annual increases in industry user fees—$828 million from manufacturers of medical and food products, including hundreds of millions drug manufacturers pay annually to help speed the review of new medicines—might compromise the agency’s independence.

Read More